Literature DB >> 1394752

Perioperative effects of oral ketorolac and acetaminophen in children undergoing bilateral myringotomy.

M F Watcha1, M Ramirez-Ruiz, P F White, M B Jones, R G Lagueruela, R P Terkonda.   

Abstract

Prophylactic administration of analgesics before surgery can decrease the intraoperative anaesthetic requirement and decrease pain during the early postoperative period. In a double-blind, placebo-controlled study involving 90 healthy ASA physical status I or II children undergoing bilateral myringotomy, we compared the postoperative analgesic effects of oral acetaminophen and ketorolac, when administered 30 min before induction of anaesthesia. Patients were randomized to receive saline (0.1 ml.kg-1), acetaminophen (10 mg.kg-1) or ketorolac (1 mg.kg-1) diluted in cherry syrup to a total volume of 5 ml. Anaesthesia was induced and maintained with halothane and nitrous oxide via a face mask. Postoperative pain was assessed by a blinded observer using an objective pain scale. The three study groups were similar with respect to demographic data, duration of anaesthesia and surgery, induction behaviour, oxygen saturation, incidence of postoperative emesis and, recovery times. The ketorolac group had lower postoperative pain scores and required less frequent analgesic therapy in the early postoperative period compared with the acetaminophen and placebo groups. In contrast, there were no differences in pain scores or analgesic requirements between the acetaminophen and the placebo groups. We conclude that the preoperative administration of oral ketorolac, but not acetaminophen, provided better postoperative pain control than placebo in children undergoing bilateral myringotomy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1394752     DOI: 10.1007/BF03008224

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  21 in total

1.  Evaluation of ketorolac, ibuprofen, acetaminophen, and an acetaminophen-codeine combination in postoperative oral surgery pain.

Authors:  J A Forbes; C J Kehm; C D Grodin; W T Beaver
Journal:  Pharmacotherapy       Date:  1990       Impact factor: 4.705

2.  [Investigations concerning serum concentration and temperature following oral application of a new paracetamol preparation (author's transl)].

Authors:  A Windorfer; C Vogel
Journal:  Klin Padiatr       Date:  1976-09       Impact factor: 1.349

3.  The prevention of postoperative pain.

Authors:  P D Wall
Journal:  Pain       Date:  1988-06       Impact factor: 6.961

4.  A postanesthetic recovery score.

Authors:  J A Aldrete; D Kroulik
Journal:  Anesth Analg       Date:  1970 Nov-Dec       Impact factor: 5.108

5.  Aspirin versus acetaminophen: a comparative view.

Authors:  B H Rumack
Journal:  Pediatrics       Date:  1978-11       Impact factor: 7.124

Review 6.  An assessment of children's pain: a review of behavioral, physiological and direct scaling techniques.

Authors:  P A McGrath
Journal:  Pain       Date:  1987-11       Impact factor: 6.961

7.  Evaluation of ketorolac, aspirin, and an acetaminophen-codeine combination in postoperative oral surgery pain.

Authors:  J A Forbes; G A Butterworth; W H Burchfield; W T Beaver
Journal:  Pharmacotherapy       Date:  1990       Impact factor: 4.705

8.  The pharmacokinetics of postoperative intravenous ketorolac tromethamine in children.

Authors:  K T Olkkola; E L Maunuksela
Journal:  Br J Clin Pharmacol       Date:  1991-02       Impact factor: 4.335

9.  Trends in medical visits and surgery for otitis media among children.

Authors:  N Croteau; V Hai; I B Pless; C Infante-Rivard
Journal:  Am J Dis Child       Date:  1990-05

10.  Ketorolac and acetaminophen for orthopedic postoperative pain.

Authors:  H J McQuay; P Poppleton; D Carroll; R J Summerfield; R E Bullingham; R A Moore
Journal:  Clin Pharmacol Ther       Date:  1986-01       Impact factor: 6.875

View more
  30 in total

Review 1.  Risks and benefits of nonsteroidal anti-inflammatory drugs in children: a comparison with paracetamol.

Authors:  C Litalien; E Jacqz-Aigrain
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

2.  Tonsillectomies, ketorolac, and the march of progress.

Authors:  S C Hall
Journal:  Can J Anaesth       Date:  1996-06       Impact factor: 5.063

Review 3.  Ketorolac. A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management.

Authors:  J C Gillis; R N Brogden
Journal:  Drugs       Date:  1997-01       Impact factor: 9.546

Review 4.  Ketorolac for postoperative pain management in children.

Authors:  J B Forrest; E L Heitlinger; S Revell
Journal:  Drug Saf       Date:  1997-05       Impact factor: 5.606

Review 5.  Minimising the adverse effects of ketorolac.

Authors:  D I Reinhart
Journal:  Drug Saf       Date:  2000-06       Impact factor: 5.606

Review 6.  Emergence Delirium in Pediatric Anesthesia.

Authors:  Arthura D Moore; Doralina L Anghelescu
Journal:  Paediatr Drugs       Date:  2017-02       Impact factor: 3.022

7.  NSAIDs and balanced analgesia.

Authors:  W Code
Journal:  Can J Anaesth       Date:  1993-05       Impact factor: 5.063

8.  A Visual Analytics Dashboard to Summarize Serial Anesthesia Records in Pediatric Radiation Treatment.

Authors:  Olivia Nelson; Brian Sturgis; Keri Gilbert; Elizabeth Henry; Kelly Clegg; Jonathan M Tan; Jack O Wasey; Allan F Simpao; Jorge A Gálvez
Journal:  Appl Clin Inform       Date:  2019-08-07       Impact factor: 2.342

9.  Pain management following myringotomy and tube placement: intranasal dexmedetomidine versus intranasal fentanyl.

Authors:  Elisabeth Dewhirst; Gina Fedel; Vidya Raman; Julie Rice; N'Diris Barry; Kris R Jatana; Charles Elmaraghy; Meredith Merz; Joseph D Tobias
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2014-04-16       Impact factor: 1.675

10.  Comparative effects of three doses of intravenous ketorolac or morphine on emesis and analgesia for restorative dental surgery in children.

Authors:  J P Purday; C C Reichert; P M Merrick
Journal:  Can J Anaesth       Date:  1996-03       Impact factor: 5.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.